Physician profile
Robert Noone
NPI 1881697845
$3,089.83
in general payments reported to CMS, 2019-2025
19 companies · $292 in 2025
The $292 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,127 · 2020: $91.82 · 2022: $56.56 · 2023: $184 · 2024: $338 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $814.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,246.37 | 2019-2025 | Da Vinci Surgical System |
| Conmed Corporation | $254.00 | 2024-2025 | Airseal, Conmed Biliary |
| Teleflex LLC | $115.32 | 2024 | Solesta |
| Medtronic, INC. | $73.80 | 2023-2025 | Ligasure, Transorb, Signia |
| Novartis Pharmaceuticals Corporation | $55.52 | 2025 | |
| Ethicon US, LLC | $54.84 | 2019-2022 | |
| Pfizer INC. | $43.45 | 2019-2024 | |
| Caris Mpi, INC. | $32.66 | 2025 | Mi Cancer Seek |
| Davol INC. | $24.00 | 2019 | |
| Abbott Laboratories | $22.11 | 2023 | Xience Skypoint |
| Innocoll Pharmaceuticals Limited | $22.08 | 2022 | |
| Incyte Corporation | $20.81 | 2025 | Zynyz, Monjuvi |
| Edwards Lifesciences Corporation | $20.00 | 2019 | |
| Kci USA, INC. | $19.72 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $18.07 | 2025 | Calquence |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $17.73 | 2024 | Axonics |
| Covidien LP | $17.70 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.66 | 2024 | |
| Mission Pharmacal Company | $13.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Noone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.